Most cited papers from Gubra (Denmark)

Gubra (Denmark)

What are the most cited papers from Gubra (Denmark)?

The most cited paper from Gubra (Denmark) is "The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss" (Anna Secher, Jacob Jelsing, Arian F. Baquero et al., 2014), with 965 citations. Next come "The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways" (517) and "Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals" (310).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 50 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss Anna Secher, Jacob Jelsing, Arian F. Baquero et al. · Journal of Clinical Investigation Open access	8 Sep 2014	965
2	The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways Günaj Rakipovski, Bidda Rolin, Jane Nøhr et al. · JACC Basic to Translational Science Open access	21 Nov 2018	517
3	Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals Malte Palm Suppli, Kristoffer T. G. Rigbolt, Sanne Skovgård Veidal et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology Open access	17 Jan 2019	310
4	Mouse models of nonalcoholic steatohepatitis in preclinical drug development Henrik H. Hansen, Michael Feigh, Sanne Skovgård Veidal et al. · Drug Discovery Today Open access	4 Jul 2017	271
5	Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Michelle L. Boland, Rhianna Che Laker, KARLY M. MATHER et al. · Nature Metabolism Open access	21 May 2020	265
6	An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) Michèle Vacca et al. · Nature Metabolism Open access238 authors	12 Jun 2024	260
7	Robust anti‐obesity and metabolic effects of a dual GLP ‐1/glucagon receptor peptide agonist in rodents and non‐human primates Susan J Henderson et al. · Diabetes Obesity and Metabolism Open access	5 Jul 2016	239
8	Nuclear morphology is a deep learning biomarker of cellular senescence Indra Heckenbach, Garik V. Mkrtchyan, Michael Ben Ezra et al. · Nature Aging Open access	15 Aug 2022	233
9	An ex vivo imaging pipeline for producing high‐quality and high‐resolution diffusion‐weighted imaging datasets Tim B. Dyrby, William F.C. Baaré, Daniel C. Alexander et al. · Human Brain Mapping Open access	14 May 2010	232
10	The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach Suryaprakash Raichur, Bodo Brunner, Maximilian Bielohuby et al. · Molecular Metabolism Open access	2 Jan 2019	200
11	Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain Kristy M. Heppner, Melissa Ann Kirigiti, Anna Secher et al. · Endocrinology Open access	7 Nov 2014	200
12	A genetic map of the mouse dorsal vagal complex and its role in obesity Mette Q. Ludwig, Wenwen Cheng, Desiree Gordian et al. · Nature Metabolism Open access	25 Mar 2021	189
13	Half‐Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation Søren B. van Witteloostuijn, Søren Ljungberg Pedersen, Knud J. Jensen · ChemMedChem	24 Oct 2016	187
14	The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease Henrik H. Hansen, Katrine Fabricius, Pernille Barkholt et al. · Journal of Alzheimer s Disease Open access	26 Jun 2015	185
15	Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight Jacob Jelsing, Niels Vrang, Gitte Hansen et al. · Diabetes Obesity and Metabolism	6 Jan 2012	178
16	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects Tea Lund Laursen, Christoffer Andersen Hagemann, Chunshan Wei et al. · World Journal of Hepatology Open access	26 Feb 2019	177
17	Enteroendocrine K and L cells in healthy and type 2 diabetic individuals Tina Jorsal, Nicolai Alexander Rhee, Jens Pedersen et al. · Diabetologia Open access	27 Sep 2017	173
18	Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis Henrik H. Hansen, Helene M. Ægidius, Denise Oró et al. · BMC Gastroenterology Open access	6 Jul 2020	161
19	CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice Chih‐Hao Wang, Morten Lundh, Accalia Fu et al. · Science Translational Medicine Open access	26 Aug 2020	155
20	Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome Andreas Nygaard Madsen, Gitte Hansen, Sarah Juel Paulsen et al. · Journal of Endocrinology Open access	27 May 2010	154
21	Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosis Aimo Kannt, Paulus Wohlfart, Andreas Nygaard Madsen et al. · British Journal of Pharmacology Open access	3 Mar 2021	139
22	Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis K.S. Tølbøl, Maria Nicoline Baandrup Kristiansen, Henrik H. Hansen et al. · World Journal of Gastroenterology Open access	14 Jan 2018	137
23	Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides Niels Vrang, Philip Just Larsen · Progress in Neurobiology	17 Jul 2010	135
24	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source Michelle L. Boland, Denise Oró, K.S. Tølbøl et al. · World Journal of Gastroenterology Open access	4 Sep 2019	132
25	Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Kristoffer T.G. Rigbolt et al. · World Journal of Hepatology Open access	2016	126
26	Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes Nicolai Alexander Rhee, Camilla D. Wahlgren, Jens Pedersen et al. · Diabetologia Open access	17 Jul 2015	121
27	Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice Mette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejá et al. · Scientific Reports Open access	30 Oct 2019	118
28	Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats Carl Frederik Hansen, Marco Bueter, Nadine Theis et al. · PLoS ONE Open access	11 Jun 2013	116
29	Membrane curvature regulates ligand-specific membrane sorting of GPCRs in living cells Kadla Røskva Rosholm, Natascha Leijnse, Anna Mantsiou et al. · Nature Chemical Biology	8 May 2017	113
30	Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy Yuliya Sharkovska, Christoph Reichetzeder, Markus Alter et al. · Journal of Hypertension	12 Sep 2014	103
31	The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy Henrik H. Hansen, Pernille Barkholt, Katrine Fabricius et al. · Brain Research	31 Dec 2015	97
32	Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis Malte Palm Suppli, Jonatan Ising Bagger, Asger Lund et al. · Diabetes	23 Jan 2020	96
33	The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis Niels Vrang, Jacob Jelsing, Lotte Simonsen et al. · American Journal of Physiology-Endocrinology and Metabolism	16 May 2012	92
34	The novel GLP ‐1‐gastrin dual agonist, ZP3022 , increases β‐cell mass and prevents diabetes in db/db mice Keld Fosgerau, Lene Jessen, Jakob L. Tolborg et al. · Diabetes Obesity and Metabolism	3 Aug 2012	92
35	Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice Louise S. Dalbøge, Dorthe L. C. Almholt, Trine S. R. Neerup et al. · PLoS ONE Open access	6 Dec 2013	89
36	An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy Johanna Perens, Casper Gravesen Salinas, Jacob Lercke Skytte et al. · Neuroinformatics Open access	15 Oct 2020	84
37	Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH Mathias Bonde Møllerhøj, Sanne Skovgård Veidal, Kirstine Tølbøl Thrane et al. · Clinical and Translational Science Open access	10 Feb 2022	83
38	Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion Peter Lykke Eriksen, Hendrik Vilstrup, Kristoffer T. G. Rigbolt et al. · Liver International	6 Aug 2019	82
39	LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men Christoffer Andersen Hagemann, Malene S. Jensen, Stephanie Kjærulff Holm et al. · Cell Reports Medicine Open access	30 Mar 2022	80
40	Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons Chloé Berland et al. · Cell Metabolism Open access	9 Mar 2020	77
41	Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery Cecilia Ratner, Louise Julie Skov, Zindy Raida et al. · Endocrinology	20 Jul 2016	75
42	INT-767 improves histopathological features in a diet-inducedob/obmouse model of biopsy-confirmed non-alcoholic steatohepatitis Jonathan David Roth, Michael Feigh, Sanne Skovgård Veidal et al. · World Journal of Gastroenterology Open access	14 Jan 2018	73
43	Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach Daniela Stols‐Gonçalves, Anne Linde Mak, Mette Simone Aae Madsen et al. · Gut Microbes Open access	14 Jun 2023	72
44	Whole-brain activation signatures of weight-lowering drugs Henrik H. Hansen, Johanna Perens, Urmas Roostalu et al. · Molecular Metabolism Open access	30 Jan 2021	72
45	Whole-brain spatial transcriptional analysis at cellular resolution Shigeaki Kanatani et al. · Science	21 Nov 2024	70
46	Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model Lone Helboe, Jan Egebjerg, Pernille Barkholt et al. · Brain Research	11 Apr 2017	68
47	Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats Bethany P. Cummings, Ahmed Bettaieb, James Lawrence Graham et al. · Disease Models & Mechanisms Open access	2012	68
48	Expression of the Fatty Acid Receptor GPR120 in the Gut of Diet-Induced-Obese Rats and Its Role in GLP-1 Secretion Sarah Juel Paulsen, Leif Kongskov Larsen, Gitte Hansen et al. · PLoS ONE Open access	10 Feb 2014	65
49	The α7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU‐120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat Gordon A. Munro, RR Hansen, H. K. Erichsen et al. · British Journal of Pharmacology Open access	27 Apr 2012	62
50	Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease Henrik H. Hansen, Katrine Fabricius, Pernille Barkholt et al. · PLoS ONE Open access	15 Jul 2016	61

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.